Eugene Schneider
Evp, Chf Clinical Develop Ofcr at Ionis Pharmaceuticals Inc (IONS)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.7M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 30SEC | IONSIonis Pharmaceuticals Inc | Sell Plan | 26,00077,114 held (−25%) | $81.05 | $2.1M | -47.0% |
| Mar 23SEC | IONSIonis Pharmaceuticals Inc | Sell Plan | 5,81263,890 held (−8%) | $70.97 | $412K | -39.5% |
| Feb 2SEC | IONSIonis Pharmaceuticals Inc | Sell | 6,17969,702 held (−8%) | $83.45 | $516K | -48.5% |
| Jan 20SEC | IONSIonis Pharmaceuticals Inc | Sell | 9,30263,890 held (−13%) | $75.59 | $703K | -43.2% |
- Sell
Evp, Chf Clinical Develop Ofcr Eugene Schneider sold $2.1M of IONS at $81.05 — cuts the stake by 25%; pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Chf Clinical Develop Ofcr Eugene Schneider sold $412K of IONS at $70.97 — pre-scheduled 10b5-1 plan sale.